Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos

Molecular Cell

Volumn 2, Issue 3, 1998, Pages 293-304

  Tsai, Kenneth Y ^a,b   Hu, Yanwen ^a,b   Macleod, Kay F ^c   Crowley, Denise ^a,e   Yamasaki, Lili ^d   Jacks, Tyler ^a,e  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; E2F1 PROTEIN, MOUSE; RETINOBLASTOMA BINDING PROTEIN 1; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1;

ANIMAL; APOPTOSIS; ARTICLE; C57BL MOUSE; CELL CYCLE; CELL CYCLE S PHASE; CONGENITAL MALFORMATION; CROSS BREEDING; EMBRYO; FETUS DEATH; GENETICS; GENOTYPE; LUNG; METABOLISM; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NICK END LABELING; PHYSIOLOGY; SKELETAL MUSCLE; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CROSSES, GENETIC; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; EMBRYO; FETAL DEATH; GENES, RETINOBLASTOMA; GENOTYPE; IN SITU NICK-END LABELING; LUNG; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; MUSCLE, SKELETAL; RETINOBLASTOMA PROTEIN; S PHASE; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS;

EID: 0032159103     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80274-9     Document Type: Article

References (69)

1. Altiok, S., Xu, M., and Spiegelman, B.M. (1997). PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev. 11, 1987-1998.
2. Attardi, L.D., Lowe, S.W., Brugarolas, J., and Jacks, T. (1996). Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15, 3693-3701.
3. Bandara, L.R., and La Thangue, N.B. (1991). Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature 351, 494-497.
4. Bartek, J., Bartkova, J., and Lukas, J. (1997). The retinoblastoma protein pathway in cell cycle control and cancer. Exp. Cell Res. 237, 1-6.
5. Beijersbergen, R.L., Kerkhoven, R.M., Zhu, L., Carlee, L., Voorhoeve, P.M., and Bernards, R. (1994). E2F-4, a new member of the E2F family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8, 2680-2690.
6. Buck, V., Allen, K.E., Sorensen, T., Bybee, A., Hijmans, E.M., Voorhoeve, P.M., Bernards, R., and La Thangue, N.B. (1995). Molecular and functional characterisation of E2F-5, a new member of the E2F family. Oncogene 11, 31-38.
7. Chellappan, S.P., Hiebert, S., Mudryj, M., Horowitz, J.M., and Nevins, J.R. (1991). The E2F transcription factor is a cellular target for the RB protein. Cell 65, 1053-1061.
8. Chen, P.L., Riley, D.J., Chen, Y., and Lee, W.H. (1996). Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interactions with C/EBPs. Genes Dev. 10, 2794-2804.
9. Chittenden, T., Livingston, D.M., and Kaelin, W.G., Jr. (1991). The T/E1A binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell 65, 1073-1082.
10. Clarke, A.R., Maandag, E.R., van Roon, M., van der Lugt, N.M.T., van der Valk, M., Hooper, M.L., Berns, A., and te Riele, H. (1992). Requirement for a functional Rb-1 gene in murine development. Nature 359, 328-330.
11. Dagnino, L., Fry, C.J., Bartley, S.M., Farnham, P., Gallie, B.L., and Phillips, R.A. (1997a). Expression patterns of the E2F family of transcription factors during mouse nervous system development. Mech. Dev. 66(1-2), 13-25.
12. Dagnino, L., Fry, C.J., Bartley, S.M., Farnham, P., Gallie, B.L., and Phillips, R.A. (1997b). Expression patterns of the E2F family of transcription factors during murine epithelial development. Cell Growth Differ. 8, 553-563.
13. DeGregori, J., Leone, G., Miron, A., Jakoi, L., and Nevins, J.R. (1997). Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94, 7245-7250.
14. de Stanchina, E., McCurrach, M.E., Zindy, F., Shieh, S.-Y., Ferbeyre, G., Samuelson, A.V., Prives, C., Roussel, M.F., Sherr, C.J., and Lowe, S.W. (1998). E1A signaling to p53 involves the p19ARF tumor suppressor. Genes Dev. 12, 2434-2442.
15. Downward, J. (1998). Ras signaling and apoptosis. Curr. Opin. Genet. Dev. 8, 49-54.
16. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C., Penn, L.Z., and Hancock, D.C. (1992). Induction of apoptosis infibroblasts by c-myc protein. Cell 69, 1083-1093.
17. Fearon, E.R. (1997). Human cancer syndromes: clues to the origin and nature of cancer. Science 278, 1043-1050.
18. Field, S., Tsai, F., Kuo, R., Zubiaga, A.M., Kaelin, W., Livingstone, D., Orkin, S., and Greenberg, M. (1996). E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 548-557.
19. Gavrieli, Y., Sherman, Y., and BenSasson, S.A. (1992). Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J. Cell Biol. 121, 899-908.
20. Ginsberg, D., Vairo, G., Chittenden, T., Xiao, Z., Xu, G., Wydner, K.L., DeCaprio, J.A., Lawrence, J.B., and Livingston, D.M. (1994). E2F-4, a new member of the E2F transcription factor family, interacts with p 107. Genes Dev. 8, 2665-2679.
21. Helin, K., Lees, J.A., Vidal, M., Dyson, N., Harlow, E., and Fattaey, A. (1992). A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70, 337-350.
22. Hiebert, S.W., Packham, G., Strom, D.K., Haffner, R., Oren, M., Zambetti, G., and Cleveland, J.L. (1995). E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol. Cell. Biol. 15, 6864-6874.
23. Hijmans, E.M., Voorhoeve, P.M., Beijersbergen, R.L., van't Veer, L.J., and Bernards, R. (1995). E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15, 3082-3089.
24. Hsieh, J.-K., Fredersdorf, S., Kouzarides, T., Martin, K., and Lu, X. (1997). E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 11, 1840-1852.
25. Ikeda, M., Jakoi, L., and Nevins, J. (1996). A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA 93, 3215-3220.
26. Ivey-Hoyle, M., Conroy, R., Huber, H.E., Goodhart, P.J., Oliff, A., and Heimbrook, D.C. (1993). Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol Cell Biol. 13, 7802-7812.
27. Jacks, T., Fazeli, A., Schmidt, E., Bronson, R., Goodell, M., and Weinberg, R.A. (1992). Effects of an Rb mutation in the mouse. Nature 359, 295-300.
28. Johnson, D.G., Schwarz, J.K., Cress, W.D., and Nevins, J.R. (1993). Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365, 349-352.
29. Jones, S.N., Roe, A.E., Donehower, L.A., Bradley, A. (1995). Rescue of embryonic lethality in Mdm-2 deficient mice by absence of p53. Nature 378, 206-208.
30. Kaelin, W.G., Jr., Krek, W., Sellers, W.R., DeCaprio, J.A., Ajchenbaum, F., Fuchs, C.S., Chittenden, T., Li, Y., Farnham, P.J., Blanar, M.A., et al. (1992). Expression cloning of a cDNA encoding a retinoblastoma binding protein with E2F-like properties. Cell 70, 351-364.
31. Kowalik, T.F., DeGregori, J., Schwarz, J.K., and Nevins, J.R. (1995). E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69, 2491-2500.
32. Kowalik, T.F., DeGregori, J., Leone, G., Jakoi, L., and Nevins, J.R. (1998). E2F-1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. Cell. Growth Differ. 9, 113-118.
33. La Thangue, N.B., Thimmappaya, B., and Rigby, P.W. (1990). The embryonal carcinoma stem cell Ela-like activity involves a differentiation-regulated transcription factor. Nucleic Acids Res. 18, 2929-2938.
34. Lee, E.Y.-H.P., Chang, C.-Y., Hu, N., Wang, Y.-C.J., Lai, C.-C., Herrup, K., and Lee, W.-H. (1992). Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288-295.
35. Lee, E.Y.-H.P., Hu, N., Yuan, S.-S.F., Cox, L.A., Bradley, A., Lee, W.-H., and Herrup, K. (1994). Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev. 8, 2008-2021.
36. Lee, M., Williams, B., Mulligan, G., Mukai, S., Bronson, R., Dyson, N., Harlow, E., and Jacks, T. (1996). Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev. 10, 1621-1632.
37. Lees, J.A., Saito, M., Vidal, M., Valentino, M., Look, T., Harlow, E., Dyson, N., and Helin, K. (1993). The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13, 7813-7825.
38. Maandag, E.C.R., van der Valk, M., Vlaar, M., Feltkamp, C., O'Brien, J., van Roon, M., van der Lugt, N., Berns, A., and te Riele, H. (1994). Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J. 13, 4260-4268.
39. Macleod, K., Hu, Y., and Jacks, T. (1996). Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J. 15, 6178-6188.
40. McCurrach, M.E., Connor, T.M., Knudson, C.M., Korsmeyer, S.J., and Lowe, S.W. (1997). bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA 94, 2345-2349.
41. Moberg, K., Starz, M.A., and Lees, J.A. (1996). E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16, 1436-1449.
42. Montes de Oca Luna, R., Wagner, D.S., and Lozano, G. (1995). Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203-206.
43. Morgenbesser, S.D., Williams, B.O., Jacks, T., and DePinho, R.A. (1994). p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371, 72-74.
44. Morkel, M., Wenkel, J., Bannister, A.J., Kouzarides, T., and Hagemeier, C. (1997). An E2F-like repressor of transcription. Nature 390, 567-568.
45. Mulligan, G., and Jacks, T. (1998). The retinoblastoma gene family: cousins with overlapping interests. Trends Genet. 14, 223-229.
46. Novitch, B., Mulligan, G., Jacks, T., and Lassar, A. (1996). Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J. Cell Biol. 135, 441-456.
47. Pan, H., Yin, C., Dyson, N., Harlow, E., Yamasaki, L., and Van Dyke, T. (1998). Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol. Cell 2, 283-292.
48. Phillips, A.C., Bates, S., Ryan, K.M., Helin, K., and Vousden, K.H. (1997). Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 11, 1853-1863.
49. Pomerantz, J., Schreiber-Agus, N., Liegeois, N.J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.W., et al. (1998). The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92, 713-723.
50. Qin, X.Q., Livingston, D.M., Kaelin, W., Jr., and Adams, P.D. (1994). Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91, 10918-10922.
51. Quelle, D.E., Zindy, F., Ashmun, R.A., and Sherr, C.J. (1995). Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993-1000.
52. Sardet, C., Vidal, M., Cobrinik, D., Geng, Y., Onufryk, C., Chen, A., and Weinberg, R.A. (1995). E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92, 2403-2407.
53. Schneider, J.W., Gu, W., Zhu, L., Mahdavi, V., and Nadal-Ginard, B. (1994). Reversal of terminal differentiation mediated by p107 in Rb-/-muscle cells. Science 264, 1467-1471.
54. Sellers, W.R., Rodgers, J.W., and Kaelin, W., Jr. (1995). A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA 92, 11544-11548.
55. Shan, B., and Lee, W.H. (1994). Deregulated expression of E2F-1 induces S-phase entry and apoptosis. Mol. Cell. Biol. 14, 8166-8173.
56. Shan, B., Zhu, X., Chen, P.L., Durfee, T., Yang, Y., Sharp, D., and Lee, W.-H. (1992). Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol Cell Biol. 12, 5620-5631.
57. Sherr, C.J. (1996). Cancer cell cycles. Science 274, 1672-1677.
58. Tevosian, S.G., Paulson, K.E., Bronson, R., and Yee, A.S. (1996). Expression of the E2F-1/DP-1 transcription factor in murine development. Cell Growth Differ. 7, 43-52.
59. Trimarchi, J.M., Fairchild, B., Verona, R., Moberg, K., Andon, N., and Lees, J.A. (1998). E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc. Natl. Acad. Sci. USA 95, 2850-2855.
60. Weinberg, R.A. (1995). The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
61. Williams, B.O., Schmitt, E.M., Remington, L., Bronson, R.T., Albert, D.M., Weinberg, R.A., and Jacks, T. (1994). Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13, 4251-4259.
62. Wu, X., and Levine, A.J. (1994). p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91, 3802-3806.
63. Yamasaki, L. (1998). Growth regulation by the E2F and DP transcription factor families. In Cell Cycle Control, M. Pagano, ed. (Berlin: Springer-Verlag), pp. 199-227.
64. Yamasaki, L., Jacks, T., Bronson, R.T., Harlow, E., and Dyson, N. (1996). Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85, 537-548.
65. Yamasaki, L., Bronson, R., Williams, B.O., Dyson, N.J., Harlow, E., and Jacks, T. (1998). Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-) mice. Nat. Genet. 18, 360-364.
66. Yin, C., Knudson, C.M., Korsmeyer, S.J., and Van Dyke, T. (1997). Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385, 637-640.
67. Zacksenhaus, E., Jiang, Z., Chung, D., Marth, J., Phillips, R., and Gallie, B. (1996). pRb controls proliferation, differentiation and death of skeletal muscle and other lineages during embryogenesis. Genes Dev. 10, 3051-3064.
68. Zhang, Y., Xiong, Y., and Yarbrough, W.G. (1998). ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92, 725-734.
69. Zindy, F., Eischen, C.M., Randle, D.H., Kamijo, T., Cleveland, J.L., Sherr, C.J., and Roussel, M.F. (1998). Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424-2433.